Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update
-
Seer Reports Third Quarter 2025 Financial Results
-
Alector Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 12, 2025
-
Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2026 Financial Results
-
Innodata Launches Federal Business Unit to Support Accelerating AI Innovation Across U.S. Government
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
-
One of the most respected leaders in cruise and luxury travel Larry Pimentel to advise and spearhead cruise industry programming at FIU Chaplin School of Hospitality & Tourism Management
-
Dropbox Announces Fiscal 2025 Third Quarter Results
-
Tennesseans for Ukraine Launches Grassroots Advocacy Initiative in the "Volunteer State"
-
Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer
-
IAA Expands Remarketing Business with U.S. General Services Administration (GSA) Relationship
-
SoundHound AI Reports Record Q3 Revenue of $42 Million, Up 68%, Raises Full Year Outlook; $269 Million in Cash
-
BioLife Solutions Reports Third Quarter 2025 Financial Results
-
Airbnb Announces Third Quarter 2025 Results
-
MARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS
-
Texas Roadhouse, Inc. Announces Third Quarter 2025 Results
-
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
-
Dorchester Minerals, L.P. Announces Third Quarter Results
-
ECW Announces US$2 Million Grant for Flood-Affected Children in Pakistan
-
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress
-
Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
-
BLINK CHARGING ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS
-
WillScot Declares Quarterly Cash Dividend
-
Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
-
Sunrun Announces Appointment of Craig Cornelius to its Board of Directors
-
Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
-
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update
-
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
-
Expedia Group Reports Third Quarter 2025 Results
-
Matisse Capital Files Application for ETF Share Class Exemptive Relief
-
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
-
AKAMAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
-
Ross Stores, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call
-
Wynn Resorts, Limited Reports Third Quarter 2025 Results
-
Doximity Announces Fiscal 2026 Second Quarter Financial Results
-
MindMed Reports Q3 2025 Financial Results and Business Updates
-
BILL Reports First Quarter Fiscal Year 2026 Financial Results
-
VTEX Reports Third Quarter 2025 Financial Results
-
The Trade Desk Reports Third Quarter 2025 Financial Results
-
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
-
Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
-
Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025
-
Progyny, Inc. Announces Third Quarter 2025 Results
-
Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
-
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
-
Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
-
Peloton Announces Q1 2026 Financial Results, Raises Full Year 2026 Adjusted EBITDA Guidance

